BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27709723)

  • 1. Road map for improvement: Point prevalence audit and survey of central venous access devices in paediatric acute care.
    Ullman AJ; Cooke M; Kleidon T; Rickard CM
    J Paediatr Child Health; 2017 Feb; 53(2):123-130. PubMed ID: 27709723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central venous Access device SeCurement And Dressing Effectiveness (CASCADE) in paediatrics: protocol for pilot randomised controlled trials.
    Ullman AJ; Kleidon T; Gibson V; Long DA; Williams T; McBride CA; Hallahan A; Mihala G; Cooke M; Rickard CM
    BMJ Open; 2016 Jun; 6(6):e011197. PubMed ID: 27259529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central venous access devices site care practices: an international survey of 34 countries.
    Broadhurst D; Moureau N; Ullman AJ
    J Vasc Access; 2016; 17(1):78-86. PubMed ID: 26349858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial.
    Ullman AJ; Kleidon T; Gibson V; McBride CA; Mihala G; Cooke M; Rickard CM
    BMC Cancer; 2017 Aug; 17(1):595. PubMed ID: 28854967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin Complications Associated With Pediatric Central Venous Access Devices: Prevalence, Incidence, and Risk.
    Ullman AJ; Kleidon TM; Turner K; Gibson V; Dean A; Cattanach P; Pitt C; Woosley J; Marsh N; Gavin N; Takashima M; Rickard CM
    J Pediatr Oncol Nurs; 2019; 36(5):343-351. PubMed ID: 31104548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central venous access device-related infections in patients with haemophilia.
    Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
    J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric central venous access devices: practice, performance, and costs.
    Ullman AJ; Gibson V; Takashima MD; Kleidon TM; Schults J; Saiyed M; Cattanach P; Paterson R; Cooke M; Rickard CM; Byrnes J; Chopra V
    Pediatr Res; 2022 Nov; 92(5):1381-1390. PubMed ID: 35136199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
    Langley AR; Stain AM; Chan A; McLimont M; Chait S; Wu J; Poon MC; Card R; Israels SJ; Laferriere N; Klaassen RJ; Rivard GE; Cloutier S; Hawes S; Feldman B; Blanchette V
    Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-associated bloodstream infections in adults with cancer: a prospective randomized controlled trial.
    Mollee P; Okano S; Abro E; Looke D; Kennedy G; Harper J; Clouston J; Van Kuilenburg R; Geary A; Joubert W; Eastgate M; Jones M
    J Hosp Infect; 2020 Oct; 106(2):335-342. PubMed ID: 32712388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center study.
    van den Bosch CH; van der Bruggen JT; Frakking FNJ; Terwisscha van Scheltinga CEJ; van de Ven CP; van Grotel M; Wellens LM; Loeffen YGT; Fiocco M; Wijnen MHWA
    J Pediatr Surg; 2019 Sep; 54(9):1894-1900. PubMed ID: 30415957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of Line Complications with KiteLock (CLiCK) in the critical care unit: study protocol for a multi-center, cluster-randomized, double-blinded, crossover trial investigating the effect of a novel locking fluid on central line complications in the critical care population.
    Ornowska M; Wong H; Ouyang Y; Mitra A; White A; Willems S; Wittmann J; Reynolds S
    Trials; 2022 Aug; 23(1):719. PubMed ID: 36042488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine Catheter Lock Solutions in Pediatric Cancer Care: A Pilot Randomized Controlled Trial of Heparin vs Saline.
    Ullman AJ; Edwards R; Walker R; Roy J; Paton A; Rickard CM; Cooke M; Bradford N; Gibson V; Cattanach P; Paterson RS; Takashima M; Byrnes J; Keogh S; Kleidon T
    Cancer Nurs; 2022 Nov-Dec 01; 45(6):438-446. PubMed ID: 35131974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of Central Venous Access Devices: A Systematic Review.
    Ullman AJ; Marsh N; Mihala G; Cooke M; Rickard CM
    Pediatrics; 2015 Nov; 136(5):e1331-44. PubMed ID: 26459655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of illness and costs among paediatric haemophilia patients with and without central venous access devices treated in US hospitals.
    Buckley B; Dreyfus J; Prasad M; Gayle J; Kendter J; Hall E
    Haemophilia; 2018 May; 24(3):e93-e102. PubMed ID: 29577531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a paediatric central venous access device database: A retrospective cohort study of practice evolution and risk factors for device failure.
    Kleidon TM; Rickard CM; Schults JA; Mihala G; McBride CA; Rudkin J; Chaseling B; Ullman AJ
    J Paediatr Child Health; 2020 Feb; 56(2):289-297. PubMed ID: 31436918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central venous access device Securement and dressing effectiveness: The CASCADE pilot randomised controlled trial in the adult intensive care.
    Mitchell ML; Ullman AJ; Takashima M; Davis C; Mihala G; Powell M; Gibson V; Zhang L; Bauer M; Geoffrey Playford E; Rickard CM
    Aust Crit Care; 2020 Sep; 33(5):441-451. PubMed ID: 31757717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator.
    McCarthy CE; O'Brien M; Andrews J; Zoland JM; Macasiray E; Wong W; Lo C; Glader B; Tamaresis J; Jeng M
    Haemophilia; 2016 Jan; 22(1):81-6. PubMed ID: 26248602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Securing jugular central venous access devices with dressings fixed to a liquid adhesive in an intensive care unit population: a randomised controlled trial.
    Pearse I; Corley A; Larsen EN; Rickard CM; Ware RS; Campbell J; Coyer F; Alexandrou E; O'Brien C; Marsh N
    Trials; 2022 May; 23(1):390. PubMed ID: 35549750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of occlusion of cEnTral lInes for children with cancer: An implementation study.
    Ullman AJ; Condon P; Edwards R; Gibson V; Takashima M; Schults J; Dean A; Cattanach P; Nicholls W; Osborne S; Rickard CM; Cooke M; Kleidon T
    J Paediatr Child Health; 2020 Dec; 56(12):1875-1884. PubMed ID: 32808404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.